Menlo Therapeutics Inc.
Pharmaceutical ManufacturingView the employees at
Menlo Therapeutics Inc.-
Mutya Harsch Chief Legal Officer, General Counsel and Secretary at Menlo Therapeutics Inc.
-
New York City Metropolitan Area
-
Rising Star
Gerson Alvarez Senior IT Professional-
San Jose, California, United States
-
Rising Star
-
Overview
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.